Literature DB >> 4136160

Letter: Mebendazole and hydatid cysts.

D D Heath, R A Chevis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4136160     DOI： 10.1016/s0140-6736(74)91517-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Enhanced bioavailability and cysticidal effect of three mebendazole-oil preparations in mice infected with secondary cysts of Echinococcus granulosus.

Authors:  Cong-shan Liu; Hao-bing Zhang; Bin Jiang; Jun-min Yao; Yi Tao; Jian Xue; Ai-dan Wen
Journal:  Parasitol Res       Date:  2012-06-04       Impact factor: 2.289

Review 2.  Bone hydatid disease.

Authors:  X H Song; L W Ding; H Wen
Journal:  Postgrad Med J       Date:  2007-08       Impact factor: 2.401

3.  In vitro effects of flubendazole on Echinococcus granulosus protoscoleces.

Authors:  M Elissondo; M Dopchiz; L Ceballos; L Alvarez; S Sánchez Bruni; C Lanusse; G Denegri
Journal:  Parasitol Res       Date:  2005-12-22       Impact factor: 2.289

4.  In vitro and in vivo effects of flubendazole on Echinococcus granulosus metacestodes.

Authors:  M Elissondo; L Ceballos; M Dopchiz; V Andresiuk; L Alvarez; S Sánchez Bruni; C Lanusse; G Denegri
Journal:  Parasitol Res       Date:  2006-12-15       Impact factor: 2.289

5.  Combined medical and surgical treatment of spinal hydatid disease: a case report.

Authors:  A G Fiennes; D G Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-10       Impact factor: 10.154

Review 6.  Chemotherapy for larval echinococcosis in animals and humans: report of a workshop.

Authors:  P M Schantz; H Van den Bossche; J Eckert
Journal:  Z Parasitenkd       Date:  1982

7.  The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man.

Authors:  M Dawson; P A Braithwaite; M S Roberts; T R Watson
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

8.  Therapy of human hydatid disease with mebendazole and albendazole.

Authors:  A Teggi; M G Lastilla; F De Rosa
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

9.  Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease.

Authors:  P A Braithwaite; M S Roberts; R J Allan; T R Watson
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Alveolar hydatid disease. Review of the surgical experience in 42 cases of active disease among Alaskan Eskimos.

Authors:  J F Wilson; R L Rausch; F R Wilson
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.